Investment Rating - The report assigns a 12-month rating of "Buy" for Alibaba Group with a price target of US$158.00, down from a prior target of US$178.00 [4][29]. Core Insights - The report anticipates a revenue increase of 1% year-over-year to Rmb246 billion for 1QFY26, impacted by the deconsolidation of 1P offline retail assets [2]. - The growth in the Taobao Tmall Group (TTG) and local services is expected to see a GMV increase of 5% year-over-year, with a faster growth in CMR at 11% year-over-year due to structural take rate improvements [2]. - Quick commerce investments are projected to reach Rmb10 billion in the quarter, leading to a significant decline in EBITA for TTG and local services [2]. - Cloud revenue growth is expected to accelerate to 22% year-over-year, driven by increased demand following the launch of DeepSeek [2]. - The international commerce segment is projected to grow by 19% year-over-year, with a narrowing EBITA loss expected [2]. Summary by Sections Revenue and Earnings Forecast - Total revenues for FY1Q26E are estimated at Rmb245.639 billion, reflecting a 1.0% year-over-year increase [10]. - The adjusted EBITA is projected at Rmb38.074 billion, down 15.5% year-over-year [10]. - Non-GAAP diluted EPS is expected to be Rmb15.2, representing a 7.7% decrease year-over-year [10]. Segment Performance - Taobao & Tmall revenues are expected to reach Rmb123.029 billion, an 8.5% increase year-over-year [10]. - Cloud revenue is anticipated to grow to Rmb32.390 billion, a 22% increase year-over-year [10]. - International commerce is expected to generate Rmb34.785 billion, an 18.7% increase year-over-year [10]. Valuation and Market Metrics - The report indicates a valuation of 13x FY26E P/E, suggesting that Alibaba remains one of the cheapest AI stocks globally [9]. - The market capitalization of Alibaba is noted to be US$254 billion, with a free float of 97% [4]. - The average daily trading volume is approximately 2,076,000 shares [4].

Investment Rating - The report maintains an "Overweight" rating for Alibaba Group Holding with a revised price target of US$150, down from US$180, indicating a potential upside of 39% from the current price of US$107.99 [7][5]. Core Insights - The report highlights that Alibaba is facing earnings pressure due to heightened investments in instant commerce, with an estimated Rmb10 billion in investments for the first quarter of fiscal year 2026, leading to a projected 16% year-over-year decline in consolidated EBITA [1][4]. - Despite the near-term earnings challenges, Alibaba is viewed as the best AI enabler in the sector, with cloud revenue expected to grow by 22% year-over-year [3][5]. Summary by Sections Earnings Forecasts - For 1QF26, total consolidated revenue is expected to increase by 2% year-over-year, while adjusted EBITA is projected to decline by 16% due to investments in food delivery and quick commerce [4][12]. - The report anticipates a significant drop in combined EBITA for the Travel and Local Services segments, with a forecasted decline of over 40% year-over-year in the second quarter [2][5]. Revenue and Profit Estimates - Revenue estimates for fiscal year 2026 have been trimmed by 4%, with adjusted EBITA forecasts reduced by 26% for FY26 and 18% for FY27 due to the impact of increased investments [5][13]. - The adjusted net profit attributable to Alibaba is expected to decrease by 23.9% for FY26, reflecting the challenges posed by the current investment strategy [13]. Valuation Methodology - The price target adjustment to US$150 is based on a discounted cash flow (DCF) analysis, with a raised weighted average cost of capital (WACC) to 11% due to increased competitive risks [14][15].

اوكي القصه كلها بلشت ب 2008 لما جايت وترافس كانوا من مؤتمر بفرنسا وطالعين يتعشوا بالمطعم الدنيا شتاء ونحن عم نحكي فصل الشتاء بفرنسا بارد كثير واثنين اصحاب عم وقفوا او واقفين عم بيستنوا التاكسي وهم عم بوقفوا او هم واقفين تحت هي الظروف البارده والطقس البارد قعدوا يف فكروا وكانوا تايم ديسابوينتد انه قد ايه صعب اليوم نلاقي تاكسي بسهوله على شان نقدر نوصل للنكست ديستنيشن ولما بلشوا يفكروا اكثر صاروا يقولوا انه لا الموضوع مش بس عشان اليوم الدنيا برد الموضوع كثير اكبر من هيك الصعوبات اللي نحن عم نواجهها مش بس عشان ...

Core Insights - Wix.com Ltd. has partnered with Monotype Imaging Inc. to significantly enhance its font library, providing users access to a diverse range of high-quality typefaces that support unique brand identities [1][2][9] - The collaboration aims to cater to various users, including small business owners, entrepreneurs, and creative agencies, by offering a globally inclusive and stylistically varied library [2][3] - Wix's commitment to improving design tools reflects its transition from a template-based website builder to a comprehensive design platform, emphasizing ease of use and extensive customization options [3] Strategic Initiatives - Wix is investing in AI capabilities, Studio, and commerce platforms to advance its strategic priorities, including a partnership with Alibaba.com to enhance global trade opportunities for digital entrepreneurs and small businesses [4] - The company has also partnered with ActiveCampaign to provide an all-in-one solution for businesses, simplifying website and marketing tools to boost customer engagement [5] - Wix aims to achieve the "Rule of 45" by 2025, focusing on balancing revenue growth with improved operating efficiencies, driven by strong execution in AI and operational cost management [6] Market Outlook - Despite ongoing economic uncertainty, Wix remains cautious about its full-year outlook, particularly regarding its Business Solutions unit, which is sensitive to consumer spending [7] - The company's stock has experienced a decline of 26% over the past six months, compared to a 5.4% decline in the Computers - IT Services industry [8]

Investment Rating - The industry investment rating is "In-Line" for Greater China Technology Semiconductors [2]. Core Insights - The report highlights the growth potential in China's AI semiconductor sector, with a forecasted capital expenditure increase of 62% year-over-year to RMB 373 billion for the top six companies [19]. - TSMC's revenue guidance for Q3 2025 indicates a potential growth of approximately 3% quarter-over-quarter in USD, but a decline of 1.6% in TWD [12]. - The report anticipates that China's local GPU market will significantly expand, with local GPU revenue projected to reach RMB 287 billion by 2027, driven by advancements in SMIC's leading node capacity [33]. Summary by Sections Valuation Comparison - TSMC's target price is set at 1,288 TWD, representing a 19% upside potential, with an estimated P/E ratio of 23.9x for 2024 [8]. - The average EPS growth for the semiconductor sector is projected at 40% for 2024, with a mean P/B ratio of 2.3x [8]. - The memory segment shows a notable upside potential for Giga Device, with a target price of 145.0 CNY, indicating a 20% upside [9]. TSMC Preview - TSMC's Q3 2025 revenue is estimated at NT$ 910 billion, with a gross profit of NT$ 508 billion, reflecting a year-over-year growth of 35.1% [12]. - The gross margin is expected to be 55.8%, while the operating margin is projected at 45.5% [12]. China AI Semiconductor Demand - The report projects that China's GPU self-sufficiency ratio will increase from 34% in 2024 to 82% by 2027, indicating a strong trend towards domestic production [28]. - The total addressable market (TAM) for cloud AI in China is expected to reach USD 48 billion by 2027 [30].

Alibaba is seeking to raise $1.5 billion from the sale of bonds exchangeable into shares of Alibaba Health Information Technology https://t.co/1tx0AFCwHF ...

Core Insights - Alibaba.com and Wix.com have formed a strategic partnership to empower digital entrepreneurs, new businesses, and SMEs to enhance their global reach [1] - The collaboration aims to facilitate seamless global trade across over 200 countries and regions [1] Strategic Initiatives - **Alibaba.com Seller App Integration with Wix Marketplace**: Wix merchants can become Global Gold Suppliers on Alibaba.com by downloading the Alibaba.com Seller App, which automates product and order synchronization, simplifying global selling processes [2] - **Smart and Efficient Sourcing from Alibaba.com for Wix Merchants**: Wix merchants will have access to a curated sourcing marketplace, allowing them to discover reliable suppliers and source products tailored to their needs, enabling quick market testing and private-label creation [3] - **Direct Access to Wix's AI Platform for Alibaba.com Sellers**: Alibaba.com sellers can build branded D2C and B2B storefronts using Wix's AI, design, marketing, and eCommerce tools, enhancing their digital presence and customer engagement [4] Leadership Statements - Kuo Zhang, President of Alibaba.com, emphasized the commitment to creating accessible global trade opportunities for businesses of all sizes, highlighting the partnership's role in simplifying international trade [5] - Nir Zohar, President of Wix, noted that the collaboration opens new opportunities for users to access international wholesale markets and strengthen customer connections [5] Future Enhancements - The partnership will roll out in phases, with anticipated features including AI-powered product discovery, automated onboarding processes, and intelligent product-matching tools aimed at benefiting small and medium-sized enterprises [5]

Investment Rating - The report maintains an "Overweight" (OW) rating for several sectors including Communication Services, Consumer Discretionary, Financials, Healthcare, and Industrials, while underweighting (UW) Energy and Utilities [7][11]. Core Insights - The report anticipates a range-bound MXCN (70-80) in the near term with potential upside in the second half of 2025, driven by factors such as strong southbound inflows into Hong Kong and a possible resolution in US-China trade negotiations [6][22]. - The forecast for MXCN/CSI300 is projected to reach HK$80/Rmb4,150 (+5.1%/5.8% from the previous close) in the base case and HK$89/Rmb4,420 (+16.8%/12.7% from the previous close) in the upside case by the end of 2025 [6][22]. - The report highlights a shift in consumer preferences from "affordable treats" to "affordable experiences," indicating a potential investment opportunity in sectors related to learning and at-home entertainment [6][8]. Summary by Sections Key Drivers for 2H25 - The report identifies key drivers for the second half of 2025, including a rebound in GDP growth and a rise in the share of sub-sectors in Recovery and Expansion [17][20]. - The business cycle profile of China equity is noted to have troughed in 3Q24, with a significant increase in the number of sectors showing recovery [17][20]. Earnings Outlook & Sector Weights - The report predicts upside for MXCN EPS compared to consensus, while forecasting downside for CSI300/CSI500/CSI1000 EPS growth due to differing sector exposures [6][7]. - Sector weights indicate a return to an Overweight stance on IT, while maintaining Overweight on Communications Services, Discretionary, Healthcare, and Materials [6][7]. Thematic Stock Screens - The report emphasizes several themes, including the rise of high yielders favored by onshore investors and the potential for financial sector consolidation [6][11]. - Top picks for 2H25 include Tencent, Alibaba, and Innovent, among others, reflecting a focus on companies with strong growth potential and favorable market conditions [6][7][11].

Investment Rating - The industry investment rating is Attractive [6]. Core Insights - The 2025 National Reimbursement Drug List (NRDL) and Commercial Insurance Drug List negotiations are set to begin, with eligibility criteria similar to previous years, including new drugs approved before June 30, 2025, and rare disease drugs [2][3]. - The role of commercial insurance in China's healthcare system is currently limited, accounting for only 7.7% of total spending on innovative drugs and devices in 2024, indicating significant potential for growth [4][8]. - The NHSA is expected to lead the formulation of the first national-level Commercial Insurance Drug List, with negotiations possibly starting in August-September 2025 [3][8]. Summary by Sections NRDL and Commercial Insurance Drug List - The NRDL negotiations may be advanced to August-September 2025 to accommodate the release of the Commercial Insurance List, anticipated in late 2025 [3]. - Eligible drugs for the Commercial Insurance List include new drugs approved from January 1, 2020, to June 30, 2025, and rare disease drugs [2]. Role of Commercial Insurance - Commercial insurance represented only 7.7% of total spending on innovative drugs and devices in China as of 2024, which is less than 5% of total healthcare expenditures [4][10]. - Strengthening the role of commercial insurers through national policy initiatives is expected to alleviate funding constraints and benefit innovative biopharma and medtech players [4]. Spending Insights - In 2024, out-of-pocket expenses accounted for RMB 78.6 billion (48%), commercial insurance for RMB 12.4 billion (8%), and basic government-funded health insurance for RMB 71 billion (44%) of the total spending on innovative drugs and devices [10].

V i e w p o i n t | 25 Jun 2025 16:16:30 ET │ 19 pages Thematic Equity Strategy A Global Perspective on Artificial Intelligence CITI'S TAKE AI remains one of our top Growth themes in the US given its premium growth expectations at justifiable valuations. In this report we take a broader look at AI across the globe and our Enablers versus Adopters value chain delineation. We reiterate the need for value chain diversification within the theme while also stressing geographic reach. Investors solely focused on ...